By VETTAPHARMA reporter – Derek Roche: GRAIL, Inc. (Nasdaq: GRAL) and Amgen (Nasdaq: AMGN) both announced that their management teams will present at the 46th Annual TD Cowen Health Care Conference, scheduled to take place in Boston in early March 2026.
GRAIL, a healthcare company focused on early cancer detection, said its leadership will present at the conference on Tuesday, March 3, 2026 at 10:30 a.m. ET. The presentation will be webcast live, and a replay will be archived in the investor relations section of GRAIL’s website for at least 30 days after the event.
Amgen also confirmed it will present at the same conference, with its session scheduled for Monday, March 2, 2026 at 1:10 p.m. ET. Senior management from Amgen, including Kave Niksefat, Senior Vice President of Global Marketing and Access, and Justin Claeys, Senior Vice President of Finance, will speak during the presentation. The webcast will be available on Amgen’s investor relations website and will be archived for at least 90 days following the event.
Both companies said their conference presentations reflect ongoing engagement with the investor community. These events offer opportunities to share updates on respective strategic priorities, scientific advances, and business outlooks with financial analysts, institutional investors, and other stakeholders.
